NCT00667121 2025-02-14
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic
Completed
Mayo Clinic
Odense University Hospital
Emory University
Gustave Roussy, Cancer Campus, Grand Paris
Odense University Hospital
University of Texas Southwestern Medical Center